Advertisement

ECMO and EVLP

  • Andreas Fiene
Chapter

Abstract

The use of extracorporeal membrane oxygenation for lung transplant patients with respiratory failure has become routine part of ICU therapy. This chapter reviews indications, complications and outcomes.

Ex-vivo lung perfusion for donor lungs is a successful strategy to identify suitable donor organs.

Keywords

Ex-vivo lung perfusion Marginal donor lung Donor lung utilisation ECMO Principles and indication Perioperative ECMO use 

References

  1. 1.
    Zapol WM, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Extracorporeal Life Support Organization. ELSO guidelines for cardiopulmonary extracorporeal life support. 2017.Google Scholar
  3. 3.
    Tsiouris A, Budev MM, Yun JJ. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: a multicenter survey. ASAIO J. 2017.Google Scholar
  4. 4.
    Hahn J, Choi JH, Chang MJ. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. J Clin Pharm Ther. 2017;42(6):661–71.CrossRefPubMedGoogle Scholar
  5. 5.
    Abrams D, Brodie D, Arcasoy SM. Extracorporeal life support in lung transplantation. Clin Chest Med. 2017;38(4):655–66.CrossRefPubMedGoogle Scholar
  6. 6.
    Langer T, et al. “Awake” extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care. 2016;20:150.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Chiumello D, et al. Extracorporeal life support as bridge to lung transplantation: a systematic review. Crit Care. 2015;19:19.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Van Raemdonck D, et al. Lung donor selection and management. Proc Am Thorac Soc. 2009;6(1):28–38.CrossRefPubMedGoogle Scholar
  9. 9.
    Steen S, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83(6):2191–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Loor G, et al. Prolonged EVLP using OCS lung: cellular and acellular perfusates. Transplantation. 2017;101(10):2303–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Linacre V, et al. Importance of left atrial pressure during ex vivo lung perfusion. J Heart Lung Transplant. 2016;35(6):808–14.CrossRefPubMedGoogle Scholar
  12. 12.
    Courtwright A, Cantu E. Evaluation and management of the potential lung donor. Clin Chest Med. 2017;38(4):751–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Cypel M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364(15):1431–40.CrossRefPubMedGoogle Scholar
  14. 14.
    Tikkanen JM, et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. J Heart Lung Transplant. 2015;34(4):547–56.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Lung Transplant QueenslandThe Prince Charles HospitalBrisbaneAustralia

Personalised recommendations